Mechanisms of aging of the extracellular matrix: Role of the elastin-laminin receptor

Gerontology

Volumn 44, Issue 6, 1998, Pages 307-317

  Robert, L ^a  

^a HÔPITAL CHARLES FOIX   (France)

Author keywords

Ageing diseases; Elastin; Elastin laminin receptor; Elastoses; Extracellular matrix; Fibronectin; Free radicals; Maillard reaction

Indexed keywords

ELASTIN; FIBRONECTIN; FREE RADICAL; HYDROLASE; LAMININ RECEPTOR;

AGING; ATHEROGENESIS; CONNECTIVE TISSUE; DEGRADATION; ELASTIC FIBER; EXTRACELLULAR MATRIX; GLYCATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

EID: 0031771028     PISSN: 0304324X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022034     Document Type: Review

References (68)

1. Robert L, Jacob MP, Fülöp T Jr, Timar J, Hörnebeck W: Elastonectin and the elastin receptor. Pathol Biol (Paris) 1989;37:736-741.
2. Robert L: Interaction between cells and elastic fibers: The elastin receptor and elastonectin. Connect Tissue Jpn 1993;25:219-225.
3. Robert L, Peterszegi G, Fülöp T: The elastin receptor in physiology and pathology: Role in vascular aging and atherogenesis; in Tamburro AM (ed): Elastin and Elastic Tissue. S. Carlo, Azienda Ospedaliera, 1997, pp 61-74.
4. Hayflick L: The coming of age of WI-38. Adv Cell Cult 1984;3:303-316.
5. Moczar M, Ouzilou J, Courtois Y, Robert L: Age dependence of the biosynthesis of intercellular matrix macromolecules of rabbit aorta in organ culture and cell culture. Gerontology 1976;22:461-472.
6. Boyer B, Kern P, Fourtanier A, Labat-Robert J: Age-dependent variations of the biosyntheses of fibronectin and fibrous collagens in mouse skin. Exp Gerontol 1991;26:375-383.
7. Rasoamanantena P, Labat-Robert J, Goldstein S: Variations de la biosynthèse et quantification de l'ARNm de la fibronectine humaine au cours du vieillissement en culture. C R Séances Soc Biol Fil 1993;187:238-246.
8. Labat-Robert J, Robert L: Modulation of collagens and fibronectin expression during ageing and age-related diseases; in Robert L, Hofecker G (eds): The Theoretical Basis of Aging Research. Vienna, Facultas Universitätsverlag, 1990, vol 2, pp 163-165.
9. Kern P, Sebert B, Robert L: Increased type III/ type I Collagen ratios in diabetic human conjunctival biopsies. Clin Physiol Biochem 1985; 4:113-119.
10. Labat-Robert J, Kern P, Robert L: Modifications of the biosynthesis of type-I and type-III collagens and fibronectin during diabetes and atherosclerosis. Z Gerontol 1991;24:66-69.
11. Fodil-Bourahla I, Drubaix I, Robert L: Effect of in vitro aging on the biosynthesis of glycsaminoglycans by human skin fibroblasts: Modulation by the elastin-laminin receptor. Mech Ageing Dev, in press.
12. Delpech B, Maingonnat C, Delpech A, Maes P, Girard N, Bertrand P: Characterization of hyaluronic acid-binding protein from sheep brain: Comparison with human brain hyaluronectin. Int J Biochem 1991;23:329-337.
13. Kern P, Regnault F, Robert L: Biochemical and ultrastructural study of human diabetic conjunctiva. Biomedicine 1976;24:32-38.
14. Robert AM, Boniface R, Robert L (eds): Biochemistry and Pathology of Basement Membranes. Front Matrix Biol. Basel, Karger, 1979, vol 7.
15. Lagrue G, Robert AM, Miskulin M, Robert L, Pinaudeau Y, Hirbec G, Kamalodine T: Pathology of the microcirculation in diabetes and alterations of the biosynthesis of intercellular matrix macromolecules; in Robert AM, Boniface R, Robert L (eds): Biochemistry and Pathology of Basement Membranes. Front Matrix Biol. Basel, Karger, 1979, vol 7, pp 324-335.
16. Velho G, Froguel P: Genetic determinants of non-insulin-dependent diabetes mellitus: Strategies and recent results. Diabète Métab 1997; 23:7-17.
17. Verzar F: Aging of the collagen fiber, in Hall DA (ed): International Review of Connective Tissue Research. Academic Press, New York, 1964, vol 2, pp 243-300.
18. Bailey AJ, Robins SP: Development and maturation of the crosslinks in the collagen fibres of skin; in Robert L, Robert B (eds): Aging of Connective Tissues - Skin. Front Matrix Biol. Basel, Karger, 1973, vol 1, pp 130-156.
19. Maillard LC: Action des acides aminés sur les sucres: Formation des mélanoïdines par voie méthodique. C R Hebd Séanc Acad Sci 1911; 66.
20. Baynes JW, Monnier VM (eds): The Maillard Reaction in Aging, Diabetes, and Nutrition. New York, Liss, 1988.
21. Vlassara H, Brownlee M, Cerami A: Macrophage receptor-mediated processing and regulation of advanced glycosylation endproduct (AGE)-modified proteins: Role in diabetes and aging; in Baynes JW, Monnier VM (eds): The Maillard Reaction in Aging, Diabetes, and Nutrition. New York, Liss, 1988, pp 205-218.
22. Vlassara H, Bucala R, Striker L: Pathogenic effects of advanced glycosylation: Biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 1994;70:138-151.
23. Vlassara H, Li YM, Imani F, Wojciechowicz D, Yang Z, Liu FT, Cerami A: Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): A new member of the AGE-receptor complex. Mol Med 1995;1:634-646.
24. Vlassara H: Advanced glycosylation in nephropathy of diabetes and aging. Adv Nephrol Necker Hosp 1996;25:303-315.
25. Hornebeck W, Derouette JC, Roland J, Chatelet F, Bouissou H, Robert L: Corrélation entre l'âge, l'artériosclérose et l'activité élastinolytique de la paroi aortique humaine. C R Acad Sci 1976;292:2003-2006.
26. Hornebeck W, Adnet JJ, Robert L: Age dependent variation of elastin and elastase in aorta and human breast cancers. Exp Gerontol 1978; 13:293-298.
27. Robert L, Labat-Robert J, Hornebeck W: Aging and atherosclerosis. Atheroscler Rev 1986;14:143-170.
28. Boyer-Lafargue B, Fourtanier A, Robert L, Labat-Robert J: Age-dependent increase of elastase-type protease activity in mouse skin: Effect of UV irradiation. Exp Geront, in press.
29. Allal M, Robert L, Labat-Robert J: Fragmentation de la fibronectine dans la mucoviscidose. C R Acad Sci 1992;314:587-592.
30. Labat-Robert J: Apport des enzymes protéolytiques à la connaisssance des fonctions biologiques de la fibronectine. Pathol Biol (Paris) 1990;38:1005-1009.
31. Marques MA, N'Doye S, Moulias R, Allard M, Labat-Robert J, Robert L: Plasma fibronectin in French centenarians. Gerontology, in press.
32. Barlati S, Adamoli A, De Petro G: Presence and role of fibronectin fragments in transformed cells; in Timpl R, Labat-Robert J, Robert L (eds): Structural Glycoproteins in Cell-Matrix Interactions. Front Matrix Biol. Basel, Karger, 1986, vol 11, pp 174-182.
33. Keil-Dlouha V, Planchenault T: Potential proteolytic activity in human plasma fibronectin. Proc Natl Acad Sci USA 1986;83:5377-5381.
34. Homandberg GA, Hui F: High concentrations of fibronectin fragments cause short-term catabolic effects in cartilage tissue while lower concentrations cause continuous anabolic effects. Arch Biochem Biophys 1994;311:213-218.
35. Homandberg GA, Meyers R, Xie DL: Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture. J Biol Chem 1992;267:3597-3604.
36. Lopez-Armada MJ, Gonzalez E, Gómez-Guerrero C, Egido J: The 80-kD fibronectin fragment increases the production of fibronectin and tumour necrosis factor-alpha. (TNF-α) in cultured mesangial cells. Clin Exp Immunol 1997;107:398-403.
37. Rice-Evans CA, Burdon RH (eds): Free Radical Damage and Its Control. Amsterdam, Elsevier, 1994.
38. Koltover VK: Free radical theory of aging: Quantitative reliability aspects and antoxidant intervention; in Viidik A, Hofecker; G (eds): Vitality, Mortality and Aging. Vienna, Facultas Universitätsverlag, 1994, pp 173-180.
39. 2+ mobilization, stimulation of respiratory burst and enzyme secretion. Biochem Biophys Res Commun 1986;141:92-98.
40. Jacob MP, Fülöp T, Foris G, Robert L: Effect of elastin peptides on ion fluxes in mononuclear cells, fibroblasts, and smooth muscle cells. Proc Natl Acad Sci USA 1987;84:995-999.
41. Archilla-Marcos M, Robert L: Control of the biosynthesis and excretion of the elastase-type protease of human skin fibroblasts by the elastin receptor. Clin Physiol Biochem 1993;10: 86-91.
42. Lafon-Cazal M, Culcasi M, Gaven F, Pietri S, Bockaert J: Nitric oxide, superoxide and peroxynitrite: Putative mediators of NMDA-induced cell death in cerebellar granule cells. Neuropharmacology 1993;32:1259-1266.
43. Faury G, Ristori MT, Verdetti J, Jacob MP, Robert L: Effect of elastin peptides on vascular tone. J Vasc Res 1995;32:112-119.
44. Faury G, Usson Y, Robert-Nicoud M, Robert L, Verdetti J: Nuclear and cytoplasmic free calcium level changes induced by elastin peptides in human endothelial cells. Proc Natl Acad Sci USA 1998;95:2967-2972.
45. Faury G, Chabaud A, Ristori MT, Robert L, Verdetti J: Effect of age on the vasodilatory action of elastin peptides. Mech Ageing Dev 1997;95:31-42.
46. Ghuysen-Itard AF, Robert L, Gourlet V, Berr C, Jacob MP: Loss of calcium-homeostatic mechanisms in polymorphonuclear leukocytes of demented and nondemented elderly subjects. Gerontology 1993;39:163-169.
47. Varga Z, Kovacs EM, Paragh G, Jacob MP, Robert L, Fülöp T: Effect of elastin peptides and N-formyl-methionyl-leucyl phenylalanine on cytosolic free calcium in polymorphonuclear leukocytes of healthy middle-aged and elderly subjects. Clin Biochem 1988;21;127-130.
48. Yamada KM: Integrin signaling. Matrix Biol 1997;16:137-141.
49. Hornebeck W., Tixier JM, Robert L: Inducible adhesion of mesenchymal cells to elastic fibers: Elastonectin. Proc Natl Acad Sci USA 1986;83: 5517-5520.
50. Groult V, Hornebeck W, Ferrari P, Tixier JM, Robert L, Jacob MP: Mechanisms of interaction between human skin fibroblasts and elastin: Differences between elastin fibres and derived peptides. Cell Biochem Funct 1991;9: 171-182.
51. Perdomo JJ, Gounon P, Schaeverbeke M, Schaeverbeke J, Groult V, Jacob MP, Robert L: Interaction between cells and elastin fibers: An ultrastructural and immunocytochemical study. J Cell Physiol 1994;158:451-458.
52. Mecham, RP, Madaras JG, Senior RM: Appearance of chemotactic responsiveness to elastin peptides by developing foetal bovine ligamentum fibroblasts parallels the onset of elastin production. J Cell Biol 1984;84:1813.
53. Varga Z, Jacob MP, Robert L, Csongor J, Fülöp T Jr: Age-dependent changes of k-elastin stimulated effector functions of human phagocytic cells: Relevance for atherogenesis. Exp Gerontol 1997;32:653-662.
54. Varga Z, Jacob MP, Robert L, Fülöp T Jr: Identification and signal transduction mechanism of elastin peptide receptor in human leukocytes. FEBS Lett 1989;258:5-8.
55. Bizbiz L, Alperovitch A, Robert L, EVA Group: Aging of the vascular wall: Serum concentration of elastin peptides and elastase inhibitors in relation with cardiovascular risk factor. The EVA Study. Atherosclerosis 1997;131: 73-78.
56. Fülöp T, Jacob MP, Khalil A, Wallach J, Robert L: Biological effects of elastin peptides. Pathol Biol (Paris), in press.
57. Fülöp T, Varga Z, Csongor J, Jacob MP, Robert L, Leovey A, Foris G: Altered phosphatidylinositol breakdown in polymorphonuclear leukocytes with aging; in Goldstein AL (ed): Biomedical Advances in Aging. Plenum Press, London, 1990, vol 17, pp 187-194.
58. Varga Z, Jacob MP, Csongor J, Robert L, Leovey A, Fülöp T Jr: Altered phosphatidylinositol breakdown after K-elastin stimulation in PMBIs of elderly. Mech Ageing Dev 1990:52: 61-70.
59. Hogg N, Darley-Usmar VM, Wilson MT, Moncada S: Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J 1992;281:419-424.
60. Darley-Usmar VM, Hogg N, O'Leary VJ, Wilson MT, Moncada S: The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic Res Commun 1992;17:9-20.
61. Peterszegi G, Robert L: Cell death induced in lymphocytes expressing the elastin-laminin receptor by excess agonists: Necrosis and apoptosis. Biomed Pharmacother, in press.
62. Roth GS: Changes in tissue responsiveness to hormones and neurotransitters during aging. Exp Gerontol 1995;30:361-368.
63. Lakatta EG: Deficient neuroendocrine regulation of the cardiovascular system with advancing age in healthy humans. Circulation 1993; 87:631-636.
64. Xiao RP, Tomhave ED, Wang DJ, Boluyl MO, Cheng H, Lakatta EG, Koch WJ: Age-associated reductions in cardiac β1- and β2-adrenergic responses without changes in inhibitory G proteins or receptor kinases. J Clin Invest 1998; 101:1273-1282.
65. Hinek A, Wrenn DS, Mecham RP, Barondes SH: The elastin receptor: A galactoside-binding protein. Science 1988;239:1539-1541.
66. Privitera-S, Prody CA, Callahan JW, Hinek A: The 67-kDa enzymaticaily inactive alternative spliced variant of β-galactosidase is identical to the elastin/laminin-binding protein. J Biol Chem 1998;273:6319-6326.
67. Robert L: Aging of vascular wall and atherogenesis: Role of the elastih-laminin receptor. Atherosclerosis 1996;123:169-179.
68. Robert L: Le cerveau et les démences. Paris, Flammarion, 1998.